14.04.2014 Views

Measles Control Program A Global and India ... - The INCLEN Trust

Measles Control Program A Global and India ... - The INCLEN Trust

Measles Control Program A Global and India ... - The INCLEN Trust

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Measles</strong> <strong>Control</strong> <strong>Program</strong><br />

A <strong>Global</strong> <strong>and</strong> <strong>India</strong> Update<br />

CHF – INCLEAN Advanced Vaccinology Course September 23, 2011<br />

Edward Hoekstra, MD, MSc, UNICEF<br />

Peter Strebel, MBChB, MPH, WHO


number of cases<br />

1980<br />

1981<br />

1982<br />

1983<br />

1984<br />

1985<br />

1986<br />

1987<br />

1988<br />

1989<br />

1990<br />

1991<br />

1992<br />

1993<br />

1994<br />

1995<br />

1996<br />

1997<br />

1998<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

2008<br />

2009<br />

2010<br />

immunization coverage (%)<br />

Overview<br />

5,000,000<br />

4,500,000<br />

4,000,000<br />

3,500,000<br />

3,000,000<br />

2,500,000<br />

2,000,000<br />

1,500,000<br />

1,000,000<br />

500,000<br />

0<br />

<strong>Measles</strong> global annual reported cases<br />

<strong>and</strong> MCV coverage, 1980 to 2010<br />

Campaigns<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

• Progress<br />

• Challenges<br />

• Opportunities<br />

Number of cases<br />

WHO/UNICEF estimates<br />

2 |


Burden of measles in 2000<br />

• 40 million cases<br />

• Complications:<br />

– 8% pneumonia<br />

– 1:1,000 encephalitis<br />

– 1:10,000 blindness<br />

• 500,000 deaths


Strategy for measles mortality reduction<br />

1. Strong routine immunization > 90%<br />

2. Provide second dose through routine<br />

or campaign<br />

3. Surveillance<br />

4. Introduction of AD syringes


Number of reported cases<br />

vaccination coverage (%)<br />

Reported measles cases <strong>and</strong> measles<br />

vaccination coverage, 1990 - 2006, Ghana<br />

45,000<br />

2001-2002<br />

campaign<br />

2006<br />

campaign<br />

100<br />

40,000<br />

90<br />

35,000<br />

30,000<br />

25,000<br />

20,000<br />

15,000<br />

10,000<br />

5,000<br />

0<br />

1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006*<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

measles cases<br />

measles vaccination coverage


<strong>Global</strong> Goals<br />

• Millennium development goal # 4 :<br />

– Reduce child deaths among children by 2/3 by 2015 ( vs. 1990 )<br />

– <strong>Measles</strong> immunization coverage indicator of access to care<br />

• By 2005<br />

– 50 % reduction in measles deaths ( achieved on time )<br />

• By 2010<br />

– 90 % reduction in measles deaths ( achieved in 5/6 WHO Regions )<br />

• By 2015<br />

– Vaccination coverage: 90 % national level <strong>and</strong> 80 % in every district<br />

– Reported incidence: < 5 cases of measles per million<br />

– Mortality reduction: 95 % ( vs 2000 )


<strong>Measles</strong> <strong>and</strong> Rubella Elimination Goals<br />

by WHO Region, August 2011<br />

Americas, Europe, E. Mediterranean, W. Pacific, Africa have measles elimination goals<br />

Americas <strong>and</strong> Europe have rubella elimination goals<br />

2015<br />

2015<br />

2000<br />

2010<br />

2015<br />

2012<br />

2020<br />

SEAR: 95% <strong>Measles</strong><br />

Mortality Reduction<br />

by 2015


Feasibility of <strong>Measles</strong> Eradication<br />

• July 2010 – <strong>Global</strong> Consultation<br />

– <strong>Measles</strong> can <strong>and</strong> should be<br />

eradicated<br />

– In the context of strengthening<br />

immunization <strong>and</strong> primary health<br />

care systems<br />

– Opportunity to accelerate rubella<br />

control <strong>and</strong> the prevention of<br />

congenital rubella syndrome<br />

– Target date of 2020 feasible if<br />

measurable progress


SAGE, November 2010<br />

• <strong>Measles</strong> can <strong>and</strong> should be eradicated<br />

• Measurable progress towards 2015 global targets <strong>and</strong><br />

existing regional elimination goals is required before<br />

establishing a target date<br />

• Requested frequent updates on progress<br />

• Executive Board (Jan 2011) endorsed SAGE approach


Progress towards 2015 global<br />

targets


Since 2000, global coverage of<br />

the first dose of measles -<br />

containing vaccine (MCV1) has<br />

increased from 72 % to :<br />

A 74 %<br />

B 78 %<br />

C 85 %<br />

D 89 %


MCV coverage (%)<br />

1980<br />

1981<br />

1982<br />

1983<br />

1984<br />

1985<br />

1986<br />

1987<br />

1988<br />

1989<br />

1990<br />

1991<br />

1992<br />

1993<br />

1994<br />

1995<br />

1996<br />

1997<br />

1998<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

2008<br />

2009<br />

2010<br />

Since 2001, 1 st dose coverage up by 12%<br />

120<br />

2015 Target<br />

100<br />

80<br />

60<br />

40<br />

20<br />

0<br />

16 19 20<br />

37 41 47 47 53 62 68 73 69 69 70 71 73 73 71 71 71 72 73 73 74 76 78 81 82 83 84 85<br />

<strong>Global</strong> AFR AMR EMR<br />

EUR SEAR WPR<br />

12 |<br />

Source: WHO/UNICEF coverage<br />

estimates, 2011 revision. Date of slide:<br />

29 July 2011


Number of MCV doses (in millions)<br />

Scaling-up 2 nd Dose Strategies<br />

Number of doses of measles vaccine administered, by delivery strategy, 2000 - 2010<br />

500<br />

450<br />

400<br />

350<br />

300<br />

<strong>Measles</strong> Initiative<br />

250<br />

200<br />

1 billion vaccinated<br />

as of July 2011<br />

150<br />

100<br />

50<br />

0<br />

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010<br />

1st routine dose 2nd routine dose SIA<br />

13 |<br />

1 st routine dose: WHO/UNICEF coverage estimates, <strong>The</strong> World<br />

Population Prospects New York, 2011. 2 nd routine dose: WHO/UNICEF<br />

Joint reporting form, (not all countries report 2 nd dose). SIA dose;: WHO<br />

SIA database, July 2011 (Provisional data)


Number of reported cases<br />

Reported measles cases<br />

down by two-thirds<br />

900000<br />

800000<br />

Reported number of measles cases by WHO Region, 2000-<br />

2010<br />

700000<br />

600000<br />

500000<br />

400000<br />

300000<br />

200000<br />

100000<br />

0<br />

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010<br />

AFR AMR EMR EUR SEAR WPR<br />

14 |<br />

Source: Cases from annual Joint Reporting Form<br />

193 WHO Member States, Data as of August 2011


1000<br />

250 500 750<br />

0<br />

Reported cases, thous<strong>and</strong>s<br />

0 400 800 1200 1600 2000<br />

Estimated <strong>Global</strong> <strong>Measles</strong> Deaths<br />

have decreased by three-quarters, 2000-2010<br />

76%<br />

2015 Target<br />

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010<br />

Year<br />

Estimated mortality<br />

Reported cases<br />

15 |<br />

PROVISIONAL ESTIMATES<br />

Source: 2010 WHO/IVB measles model, Sept 2011<br />

Shading indicates uncertainty bounds


% Reduction<br />

Reduction in Estimated <strong>Measles</strong> Deaths by<br />

WHO Region 2000 to 2010<br />

0<br />

-10<br />

-20<br />

AMR EUR AFR WPR EMR SEAR* <strong>India</strong> GLOBAL<br />

26%<br />

-30<br />

-40<br />

-50<br />

87% 85% 79% 78%<br />

85%<br />

76%<br />

-60<br />

-70<br />

-80<br />

-90<br />

-100<br />

95% 2015 reduction goal<br />

16 |<br />

* SEAR excluding <strong>India</strong><br />

Source: 2010 measles burden model,<br />

WHO/IVB, September 2011


Major causes of mortality among children


Deaths Averted<br />

<strong>Measles</strong> Deaths Averted, 2000-2010<br />

2,000<br />

1,800<br />

1,600<br />

1,400<br />

1,200<br />

5.0 million deaths<br />

averted (32%)<br />

1,000<br />

800<br />

600<br />

400<br />

10.8 million deaths<br />

averted (68%)<br />

200<br />

-<br />

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010<br />

Total deaths averted with SIA <strong>and</strong> improved RI<br />

Total deaths averted by sustaining year 2000 RI coverage<br />

18 |<br />

*Provisional estimates<br />

Based on method of Wolfson et al, Lancet 2007


Challenges


# 1: <strong>India</strong><br />

• 134 million children need<br />

vaccination<br />

• High quality<br />

– Coverage >90%<br />

– Immunization safety including<br />

needle disposal<br />

20 |


Estimated <strong>Measles</strong> Mortality, <strong>India</strong><br />

60000<br />

50000<br />

40000<br />

30000<br />

20000<br />

10000<br />

0<br />

Arunachal Pradesh<br />

Manipur<br />

J & K<br />

Tripura<br />

Source: <strong>Measles</strong> Strategic Planning model<br />

60,000- 100,000 estimated<br />

deaths<br />

Meghalaya<br />

Nagal<strong>and</strong><br />

Punjab<br />

Uttarakh<strong>and</strong><br />

Haryana<br />

Karnataka<br />

Chattisgarh<br />

Maharashtra<br />

Gujarat<br />

Orissa<br />

Andhra Pradesh<br />

West Bengal<br />

Assam<br />

Jharkh<strong>and</strong><br />

Madhya Pradesh<br />

Rajasthan<br />

Bihar<br />

Uttar Pradesh<br />

>80% deaths


MCV1: Coverage of <strong>Measles</strong> containing vaccine<br />

per DLHS-3; CES-06 for Nagal<strong>and</strong><br />

2 nd Dose of <strong>Measles</strong> vaccine:<br />

State specific delivery strategies<br />

SIA: MCV1 < 80%<br />

RI: MCV1 > 80%


2 nd Dose of<br />

<strong>Measles</strong> in RI<br />

• 17 states (MCV1 > 80 %)<br />

introduced measles 2 nd<br />

dose in their routine<br />

immunization program<br />

• 45 districts, who<br />

completed measles<br />

campaign in phase -1 are<br />

in process of introducing<br />

2 nd dose in their RI<br />

program


MCV2 introduction through Supplementary<br />

Immunization Activity (SIA) in Phases<br />

Phase 1<br />

• Initiated in November 2010;<br />

• 45 districts from 13 states<br />

o 9 district from Chhattisgarh<br />

o 5 districts from each of the 6<br />

states (Bihar, Jharkh<strong>and</strong>,<br />

Rajasthan, Madhya Pradesh,<br />

Gujarat & Haryana)<br />

o 1 district from each of the 6<br />

North-East states<br />

• Approximately 14 million target<br />

children 9 months – 10 yrs


<strong>Measles</strong> SIA plan, <strong>India</strong><br />

Phase 1, 45 districts covered<br />

Phase 2 A (144 districts)<br />

Phase 2 B (81 districts)<br />

Phase 3 (91 districts)<br />

Total target- 135 million children<br />

Districts- 361


No. of cases (in thous<strong>and</strong>s)<br />

MCV1 coverage (%)<br />

# 2: Resurgence in Africa<br />

• 4-fold increase since 2008<br />

600,000<br />

500,000<br />

400,000<br />

100<br />

90<br />

80<br />

70<br />

60<br />

• Large outbreaks in Burkina<br />

Faso (2009), S. Africa (2010),<br />

<strong>and</strong> DRC (2011)<br />

300,000<br />

200,000<br />

100,000<br />

Number of cases<br />

WHO/UNICEF estimates<br />

Administrative coverage<br />

50<br />

40<br />

30<br />

20<br />

• Outbreaks in drought affected<br />

Horn of Africa<br />

– High case-fatality<br />

10<br />

0<br />

0<br />

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010‡<br />

Year<br />

26 |<br />

Weekly Epidemiological Record<br />

(2011) 86:129-136


# 3: Weak Immunization Systems<br />

<strong>Measles</strong> 1 st dose coverage among infants, 2010<br />

• 1 st dose:<br />

– 67 Countries have<br />

MCV1 coverage


$ US Million<br />

# 4: Financing is late <strong>and</strong> unpredictable<br />

180<br />

<strong>Measles</strong> Initiative Annual Donations, 2001-2011*<br />

160<br />

140<br />

120<br />

100<br />

80<br />

60<br />

40<br />

20<br />

0<br />

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011<br />

*Excluding country contributions<br />

Donations<br />

28 |


Summary<br />

• <strong>Measles</strong> strategy works<br />

• Achievements<br />

– 1 st dose coverage up to 85%<br />

– 1 billion doses delivered in campaigns<br />

– 2 / 3 reduction in cases<br />

– 3 / 4 reduction in deaths<br />

• Challenges<br />

– Cases <strong>and</strong> deaths unchanged in past 3 years<br />

29 |


Anne Ray Charitable <strong>Trust</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!